Intermittent urethral infusion of dimethylsulfoxide for urethral amyloidosis: a case report and literature review

Abstract Urethral amyloidosis (UA) is a very rare condition. We here report the case of a 63-year-old male patient who was admitted to our outpatient department due to aggravating dysuria, frequent urination, pain during intercourse, and a gradually enlarging mass at the ostium of his urethra, which he first notice one year earlier. Pathological tissue biopsy of urethral ostium mass confirmed UA. Intermittent urethra infusion of dimethyl sulfoxide was performed and the treatment effect is satisfactory.

• Publication year

  2022

• Venue

  The Aging Male

• Publication date

  2022-07-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1080/13685538.2022.2097220PMID 35815465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Benefits of urethroplasty for managing urethral amyloidosis: A case report

  2017cited by this paper
• The use of dimethylsulfoxide as a solvent in enzyme inhibition studies: the case of aldose reductase

  2017cited by this paper
• DMSO Represses Inflammatory Cytokine Production from Human Blood Cells and Reduces Autoimmune Arthritis

  2016cited by this paper
• Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.

  2014cited by this paper
• What is the evidence for the management of urethral amyloidosis? A systematic review of the literature

  2012cited by this paper
• Imaging evaluation of amyloidosis of the urinary tract and retroperitoneum.

  2011cited by this paper
• Amyloidosis: diagnosis and management.

  2005cited by this paper
• Primary localized amyloidosis of the urethra in a woman.

  1998cited by this paper

• No citing papers are available for this paper.